Bristol-Myers Squibb is engaged in ongoing, costly patent litigation against multiple generic companies challenging its key products. These legal battles create financial uncertainty and operational distraction, increasing the need for efficient legal and risk management solutions.
Filing excerpt
From time to time, ANDAs including Paragraph IV certifications are filed with respect to certain of our products. We evaluate these ANDAs on a case-by-case basis and, where warranted, file suit against the generic manufacturer to protect our patent rights.
What this signalsFilings often name leadership changes, deals and spending plans.
Competitors
Regions named
sec-10klitigationMaterialGet every 10-K signal for Bristol Myers Squibb and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bristol Myers Squibb this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/24ad3120-3e57-4363-821d-da1da6a843b0 returns this record as JSON. POST /v1/companies/enrich returns every signal for bms.com.
{
"signal_id": "24ad3120-3e57-4363-821d-da1da6a843b0",
"signal_type": "sec-10k",
"signal_subtype": "litigationMaterial",
"detected_at": "2026-02-17T06:30:02.078+00:00",
"company": {
"name": "Bristol Myers Squibb",
"domain": "bms.com"
},
"data": {
"detail": "Bristol-Myers Squibb is engaged in ongoing, costly patent litigation against multiple generic companies challenging its key products. These legal battles create financial uncertainty and operational distraction, increasing the need for efficient legal and risk management solutions.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Actively litigating against generic manufacturers to defend key product patents",
"excerpts": "From time to time, ANDAs including Paragraph IV certifications are filed with respect to certain of our products. We evaluate these ANDAs on a case-by-case basis and, where warranted, file suit against the generic manufacturer to protect our patent rights.",
"relevance": 0.8,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/bmy-20251231.htm",
"filing_date": "2026-02-11",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Legal tech opportunity",
"signal_category": "risk",
"regions_mentioned": [
"U.S."
],
"competitors_mentioned": [
"Pfizer"
]
}
}
curl https://signals.autobound.ai/v1/signals/24ad3120-3e57-4363-821d-da1da6a843b0 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bms.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.